Discussion: quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A
- PMID: 24165607
- DOI: 10.1097/PRS.0b013e3182a4c2c3
Discussion: quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A
Comment on
-
Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A.Plast Reconstr Surg. 2013 Nov;132(5):1255-1264. doi: 10.1097/PRS.0b013e3182a48d16. Plast Reconstr Surg. 2013. PMID: 24165606
References
-
- Salles AG, Toledo PN, Ferreira MC. Botulinum toxin injection in long-standing facial paralysis patients: Improvement of facial symmetry observed up to 6 months. Aesthetic Plast Surg. 2009;33:582–590
-
- Terzis JK, Karypidis D. Therapeutic strategies in post-facial paralysis synkinesis in adult patients. Plast Reconstr Surg. 2012;129:925e–939e
-
- Clark RP, Berris CE. Botulinum toxin: A treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg. 1989;84:353–355
-
- Toffola ED, Furini F, Redaelli C, Prestifilippo E, Bejor M. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil. 2010;32:1414–1418
-
- Salles AG, Ferreira MC. Botulinum toxin in the treatment of the synkinesis associated with facial paralysis: Preliminary report. Plast Reconstr Surg. 2012;130:49–50
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical